glp-1 trials Cardiovascular outcomes in major with receptor agonists Results of cardiovascular outcomes trials
Description
Bay Staters use of weight-loss medications, such as Ozempic and Wegovy, has surged in recent years, and health policy officials are concerned about the impact of the soaring drug prices on overall pharmaceutical spending
While these results are certainly encouraging, they should be regarded as preliminary
There is no published evidence of false-positive cross-reactivity and low plausibility given semaglutide's peptide structure
The absence of faecal elastase testing in the diagnosis and management of chronic pancreatitis
Highmark has issued communications to existing users & prescribers of impacted medications
